Physician profile
Alan Schrager
NPI 1598772766
$2,254.43
in general payments reported to CMS, 2019-2025
10 companies · $55.32 in 2025
The $55.32 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $78.11 · 2021: $1,524 · 2022: $112 · 2023: $222 · 2024: $41.19 · 2025: $55.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.75 |
| Education | $150.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,050.54 | 2019-2021 | |
| Astellas Pharma US INC | $641.59 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $145.11 | 2023-2025 | Orgovyx, Gemtesa |
| Urovant Sciences INC | $125.61 | 2021-2022 | |
| Myovant Sciences INC. | $104.19 | 2021-2022 | |
| Blue Earth Diagnostics | $84.53 | 2021 | |
| Allergan, INC. | $40.80 | 2019 | |
| Progenics Pharmaceuticals, INC. | $23.64 | 2023 | Pylarify |
| Pfizer INC. | $22.60 | 2020 | |
| Dentsply Ih INC. | $15.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Schrager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.